Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases

Current treatment strategies of autoimmune diseases (ADs) display a limited efficacy and cause numerous adverse effects. Phosphodiesterase (PDE)4 and PDE7 inhibitors have been studied recently as a potential treatment of a variety of ADs. In this study, a PK/PD disease progression modeling approach...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Artur Świerczek (Autor), Krzysztof Pociecha (Autor), Hanna Plutecka (Autor), Marietta Ślusarczyk (Autor), Grażyna Chłoń-Rzepa (Autor), Elżbieta Wyska (Autor)
Formato: Libro
Publicado: MDPI AG, 2022-05-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible